Accession Number : ADA588292


Title :   Protein Phosphatase 2A Signaling in Human Prostate Cancer


Descriptive Note : Annual rept. 1 Feb 2012-6 May 2013


Corporate Author : UNIVERSITY OF SOUTH ALABAMA MOBILE


Personal Author(s) : Singh, Ajay


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a588292.pdf


Report Date : Jun 2013


Pagination or Media Count : 23


Abstract : Advanced prostate cancers (PCa) treated with first line androgen-deprivation therapy (ADT) eventually relapse in a hormone refractory or castration-resistant (CR) form. Relapsed disease is highly aggressive and poses an increased risk of morbidity and death. Previously, we demonstrated that PPP2CA, which encodes the catalytic-subunit (alpha-isoform) of the protein phosphatase 2A (PP2AC ), is downregulated in CR PCa. The level of PP2AC was decreased in majority of CR PCa cell lines and cancer lesions as compared to the adjacent normal/benign tumor tissues. Under this project, we have utilized multiple approaches to demonstrate a functional role of PP2A in human prostate cancer progression. We have shown that PP2A downregulation promotes growth, androgen depletion-resistance and aggressive behavior of prostate cancer cells. We have also developed in vivo experimental support for a suppressor role of PP2A in prostate cancer progression using orthotopic mouse model. Furthermore, we delineated the molecular mechanisms involved in the PP2A-mediated growth and aggressive phenotypes of PCa cells. We observed PP2A downregulation facilitates castration-resistant growth of PCa cells in both androgen receptor (AR)- dependent and independent manners in AR expressing (LNCaP and C4-2) cells. Moreover, we identified that PPP2CA downregulation favors EMT, migration and invasion of PCa cells through Akt-dependent activation of -catenin and NF- B pathway. Our data strongly suggest that downregulation of PP2A is associated with human prostate cancer progression and restoration of PP2A activity may be an effective approach for the treatment of the advanced disease.


Descriptors :   *PROSTATE CANCER , ANDROGENS , CELLS(BIOLOGY) , GROWTH(PHYSIOLOGY) , HORMONES , LESIONS , PHOSPHATASES , PROTEINS


Subject Categories : Medicine and Medical Research


Distribution Statement : APPROVED FOR PUBLIC RELEASE